middle.news
Biotron Expands Horizons: Hepatitis B Progress Meets Sedarex Acquisition
12:01pm on Thursday 30th of October, 2025 AEDT
•
Healthcare
Read Story
Biotron Expands Horizons: Hepatitis B Progress Meets Sedarex Acquisition
12:01pm on Thursday 30th of October, 2025 AEDT
Key Points
Continued evaluation of lead Hepatitis B compound in animal models
Appointment of Michael Medway as Non-Executive Director
Acquisition of Sedarex Limited pending shareholder approval
$2.5 million capital raising via placement and rights issue
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biotron (ASX:BIT)
OPEN ARTICLE